Mounjaro

Mounjaro (Tirzepatide) has quickly become one of the most talked about medications in 2022. I have seen a significant uptick in patients calling or asking questions about this medication. As a pharmacist, I am always interested to hear about my patient's experiences with different medicines. The feedback I've received about Mounjaro is that it has made a big difference in patient's life and helped with weight loss.

I wanted to learn more about it, so I joined several Facebook groups to gauge a broader view of the medication. There are lots of stories on there, I could spend all day reading the comments, but the overall takeaway is that people are pleased with the results of the medication.

Something that often comes up is the price of the medication and the fact that most insurance companies are not covering it. However, as a pharmacist, I see many savings cards and have had no trouble processing them and getting the patient the $25.00 copay.

A significant concern is that the medication is on short supply. I've heard stories that people struggle to find the strength they need and must either dose up or down, depending on what is available.

This is not medical advice, just some things I've observed as a pharmacist. I always advise patients to speak with their doctors to ensure the medication is right for them.